Ghizal Siddiqui

Ghizal Siddiqui is a Research Fellow at Monash University's Department of Drug Delivery Disposition & Dynamics. Her work focuses on multi-omics approaches to combat malaria, including proteomics, metabolomics, and phosphoproteomics. She investigates mechanisms of drug resistance in Plasmodium parasites, particularly artemisinin resistance linked to Kelch13 mutations. Her research aims to develop new antimalarial strategies by targeting redox pathways and parasite metabolism.

Education and career: Postdoctoral researcher with a strong focus on malaria parasitology. Currently supervising PhD students and actively contributing to drug discovery initiatives.

Key research interests include antimalarial drug mechanisms, parasite-host interactions, and translational proteomics. She has pioneered studies showing how increased glutathione levels in resistant parasites contribute to drug tolerance, leading to novel redox-based therapeutic strategies.

• Collaborations: Extensive international partnerships in malaria research, including work with institutions in South-East Asia
• Expertise: Mass spectrometry, omic data integration, drug resistance modeling

Awards: 12+ accolades including APS Travel Awards, Best Poster Prizes, and institutional recognitions for her impactful malaria research contributions.